Tags

Type your tag names separated by a space and hit enter

Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss.
Rhinology. 2020 Aug 01; 58(4):400-401.R

Abstract

Since December 2019, a novel coronavirus SARS-CoV-2 (Covid-19) outbreak emerged in China and spread rapidly in several countries. As of April 5, 2020, 1.218.474 cases were confirmed with 65.884 deaths worldwide (1). The clinical manifestations of Covid-19 range from asymptomatic carrier status to severe pneumonia. In a study of 7,736 Covid-19 patients in China, of all the clinical symptoms, hyposmia was not reported in any patient(2). Anyway, it is now clear that olfactory dysfunction may also be present in these patients(3) as the only or prevalent manifestation(4).

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Ottaviano G
Department of Neurosciences, Otolaryngology Section, University of Padova, Padova, Italy.
Carecchio M
Department of Neurosciences, Neurological Section, University of Padova, Padova, Italy.
Scarpa B
Department of Statistical Sciences and Department of Mathematics Tullie Levi-Cijita, University of Padova, Padova, Italy.
Marchese-Ragona R
Department of Neurosciences, Otolaryngology Section, University of Padova, Padova, Italy.

MeSH

BetacoronavirusCOVID-19ChinaCoronavirus InfectionsHumansOlfaction DisordersPandemicsPneumonia, ViralSARS-CoV-2

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32338254

Citation

Ottaviano, G, et al. "Olfactory and Rhinological Evaluations in SARS-CoV-2 Patients Complaining of Olfactory Loss." Rhinology, vol. 58, no. 4, 2020, pp. 400-401.
Ottaviano G, Carecchio M, Scarpa B, et al. Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss. Rhinology. 2020;58(4):400-401.
Ottaviano, G., Carecchio, M., Scarpa, B., & Marchese-Ragona, R. (2020). Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss. Rhinology, 58(4), 400-401. https://doi.org/10.4193/Rhin20.136
Ottaviano G, et al. Olfactory and Rhinological Evaluations in SARS-CoV-2 Patients Complaining of Olfactory Loss. Rhinology. 2020 Aug 1;58(4):400-401. PubMed PMID: 32338254.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss. AU - Ottaviano,G, AU - Carecchio,M, AU - Scarpa,B, AU - Marchese-Ragona,R, PY - 2020/4/28/pubmed PY - 2020/9/1/medline PY - 2020/4/28/entrez SP - 400 EP - 401 JF - Rhinology JO - Rhinology VL - 58 IS - 4 N2 - Since December 2019, a novel coronavirus SARS-CoV-2 (Covid-19) outbreak emerged in China and spread rapidly in several countries. As of April 5, 2020, 1.218.474 cases were confirmed with 65.884 deaths worldwide (1). The clinical manifestations of Covid-19 range from asymptomatic carrier status to severe pneumonia. In a study of 7,736 Covid-19 patients in China, of all the clinical symptoms, hyposmia was not reported in any patient(2). Anyway, it is now clear that olfactory dysfunction may also be present in these patients(3) as the only or prevalent manifestation(4). SN - 0300-0729 UR - https://www.unboundmedicine.com/medline/citation/32338254/Olfactory_and_rhinological_evaluations_in_SARS_CoV_2_patients_complaining_of_olfactory_loss_ DB - PRIME DP - Unbound Medicine ER -